Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1976
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15.4M | ﹤0.01% |
604,163
-30,115
| -5% | -$885K |
|
1977
Malibu Boats
MBUU
$541M
| $15.4M | ﹤0.01% |
219,843
-6,838
| -3% | -$514K |
|
1978
Iovance Biotherapeutics
IOVA
$1.82B
| $15.3M | ﹤0.01% |
622,214
-37,492
| -6% | -$883K |
|
1979
Penske Automotive Group
PAG
$14.3B
| $15.3M | ﹤0.01% |
152,102
-15,187
| -9% | -$1.33M |
|
1980
Hyatt Hotels
H
$16.4B
| $15.3M | ﹤0.01% |
198,244
+7,477
| +4% | +$564K |
|
1981
The Joint Corp
JYNT
$118M
| $15.3M | ﹤0.01% |
155,672
-3,918
| -2% | -$367K |
|
1982
Enviri
NVRI
$623M
| $15.2M | ﹤0.01% |
899,639
-5,248
| -0.6% | -$97K |
|
|
CDMO
1983
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $15.2M | ﹤0.01% |
705,868
-22,612
| -3% | -$546K |
|
1984
Stride
LRN
$3.41B
| $15.2M | ﹤0.01% |
423,137
-2,626
| -0.6% | -$86.1K |
|
|
WW
1985
DELISTED
WW International
WW
| $15.2M | ﹤0.01% |
831,879
-133,523
| -14% | -$3.49M |
|
1986
Safety Insurance
SAFT
$1.52B
| $15.2M | ﹤0.01% |
191,293
-6,877
| -3% | -$543K |
|
1987
RadNet
RDNT
$5.02B
| $15.2M | ﹤0.01% |
517,105
-7,837
| -1% | -$251K |
|
|
SHOE
1988
Shoe Station Group
SHOE
$413M
| $15.1M | ﹤0.01% |
466,885
-18,811
| -4% | -$656K |
|
|
SCS
1989
DELISTED
Steelcase
SCS
| $15.1M | ﹤0.01% |
1,193,425
-31,474
| -3% | -$434K |
|
1990
Bionano Genomics
BNGO
$12.3M
| $15.1M | ﹤0.01% |
4,586
+2,716
| +145% | +$9.5M |
|
1991
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $15.1M | ﹤0.01% |
146,357
-10,691
| -7% | -$1.13M |
|
|
PRA
1992
DELISTED
ProAssurance
PRA
| $15.1M | ﹤0.01% |
635,686
-10,614
| -2% | -$245K |
|
|
SHYF
1993
DELISTED
The Shyft Group
SHYF
| $15.1M | ﹤0.01% |
397,402
-12,056
| -3% | -$488K |
|
1994
Atara Biotherapeutics
ATRA
$75.5M
| $15.1M | ﹤0.01% |
33,730
-1,142
| -3% | -$409K |
|
1995
National Healthcare
NHC
$3.53B
| $15M | ﹤0.01% |
214,617
-2,207
| -1% | -$161K |
|
1996
StoneX
SNEX
$9.26B
| $15M | ﹤0.01% |
1,152,195
+284
| +0% | +$3.65K |
|
1997
Griffon
GFF
$3.95B
| $15M | ﹤0.01% |
609,628
-16,551
| -3% | -$395K |
|
1998
Surgery Partners
SGRY
$2.01B
| $15M | ﹤0.01% |
353,617
-6,313
| -2% | -$322K |
|
1999
LeMaitre Vascular
LMAT
$2.32B
| $15M | ﹤0.01% |
281,720
+8,348
| +3% | +$470K |
|
2000
STMicroelectronics
STM
$46.7B
| $15M | ﹤0.01% |
342,795
-82,722
| -19% | -$3.49M |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.